← Back to Screener
Jyong Biotech Ltd. Ordinary Shares (MENS)
Price$2.02
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-100.50%
Price vs S&P 500 (4W)-1.45%
VGM Score33.34
Market Capitalization$153.58M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-57.02%
EPS (TTM)$-0.08
10-Day Avg Trading Volume0.06M
EPS Excl Extra (TTM)$-0.08
EPS (Annual)$-0.06
Cash / Share (Quarterly)$0.02
ROA (Last FY)-22.48%
EBITD / Share (TTM)$-0.05
Cash Flow / Share (Annual)$-0.04
Net Income / Employee (Annual)$-161,100
Net Interest Coverage (TTM)-1.42x
ROA (TTM)-20.27%
EPS Incl Extra (Annual)$-0.06
Current Ratio (Annual)0.45x
Quick Ratio (Quarterly)0.42x
3-Month Avg Trading Volume0.20M
Revenue / Employee (TTM)$0
52-Week High$67.00
EPS Excl Extra (Annual)$-0.06
26-Week Price Return-92.57%
Quick Ratio (Annual)0.42x
13-Week Price Return-8.18%
Current Ratio (Quarterly)0.45x
Enterprise Value$170.84M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.02
3-Month Return Std Dev83.57%
Net Income / Employee (TTM)$-204,200
Net Interest Coverage (Annual)-1.55x
EPS Basic Excl Extra (Annual)$-0.06
EPS Incl Extra (TTM)$-0.08
Revenue / Share (Annual)$0.00
Year-to-Date Return-48.86%
5-Day Price Return-1.94%
EPS Normalized (Annual)$-0.06
Month-to-Date Return-8.18%
EBITD / Share (Annual)$-0.03
EPS Basic Excl Extra (TTM)$-0.08
Price vs S&P 500 (13W)-16.44%
Beta3.08x
Revenue / Share (TTM)$0.00
52-Week Low$1.43
mGradeD
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MENSJyong Biotech Ltd. Ordinary Shares | — | — | D | $2.02 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Jyong Biotech is a Taiwan-based biotechnology company focused on developing plant-derived therapeutics for urinary system diseases. Its pipeline includes a lead candidate in NDA submission, a clinical-stage program, and preclinical assets, targeting the U.S., European, and Asian markets.